本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corbus Pharmaceuticals Holdings, Inc.

10.14
+0.14001.40%
盤後10.10-0.0400-0.39%19:06 EDT
成交量:17.46萬
成交額:176.17萬
市值:1.80億
市盈率:-1.72
高:10.27
開:9.97
低:9.93
收:10.00
52周最高:20.56
52周最低:5.75
股本:1,773.65萬
流通股本:1,274.79萬
量比:0.83
換手率:1.37%
股息:- -
股息率:- -
每股收益(TTM):-5.9000
每股收益(LYR):-5.9000
淨資產收益率:-54.18%
總資產收益率:-32.91%
市淨率:1.22
市盈率(LYR):-1.72

資料載入中...

2021/03/15

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/15

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/04

重要事件披露

8-K - Current report
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/27

重要事件披露

8-K - Current report
2021/01/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/04

重要事件披露

8-K/A [Amend] - Current report
2020/11/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/16

重要事件披露

8-K - Current report
2020/11/10

重要事件披露

8-K - Current report
2020/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/06

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/10/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/10/08

重要事件披露

8-K - Current report
2020/10/06

重要事件披露

8-K - Current report
2020/09/25

重要事件披露

8-K - Current report